Izindaba

I-NEW YORK, Juni 23, 2022 (GLOBE NEWSWIRE) - I-Reportlinker.com imemezela ukukhishwa kombiko "I-Global Intravenous Therapy kanye ne-Intravenous Access Market size, Share and Industry Trends Analysis Report, Outlook and Forecast by End User, Application, Type, Region , 2022-2028″ – https://www.reportlinker.com/p06283441/?utm_source=GNW Indlela eshesha kakhulu yokufaka uketshezi ezingxenyeni ezihlukene zomzimba iwukwelashwa nge-IV.Inhliziyo, unhlangothi, kanye nobuthi konke kwelashwa nge lesi sidakamizwa.Kulokhu, isiguli kufanele selashwe ngomuthi ngokushesha ngangokunokwenzeka, ngaleyo ndlela sinikeze umuthi ngomthambo.Imithi yokwelapha ngamakhemikhali, ama-antibiotic, ama-antifungal, amaphilisi ezinhlungu, ama-immune globulin zokwelapha, nemithi yomfutho wegazi inikezwa ngomthambo. (IV) kuyindlela yokulethwa kwemithi noketshezi emzimbeni ngomthambo.Imithi equkethe amavithamini namaminerali inikezwa nge-drip efakwe emthanjeni noma ngomjovo, okuvumela ukwelashwa ukuthi kugeleze ngokushesha egazini.Ngokwe-Scope, ukuphathwa kwe-IV yilapho isiguli sisebenzisa ishubhu elibizwa ngokuthi i-cannula ukufaka izinto ngqo emithanjeni.Lokhu kungaba umphumela omubi wemithi noma ukuntuleka kokudla okunomsoco.Ukwelashwa kwe-IV kuyindlela evamile yokuhlinzeka ngoketshezi, izidakamizwa, ukwelapha ngamakhemikhali, kanye nokumpontshelwa igazi ezigulini eziphelelwe amanzi emzimbeni. .Ngesikhathi sokuphathwa kwe-IV, imishini ehlukahlukene ye-IV efana ne-IV catheter, amaphampu okufakwayo, amadivaysi e-immobilization, kanye nezinsiza zokuphatha zisetshenziswa.Ukuphathwa kokwelashwa kwe-IV kuyashesha, kulula ukulandela, futhi akunayo imiphumela emibi yesisu.Kukhuthaza ukusabela okusheshayo kwamasosha omzimba futhi ikhulula izifo ezingelapheki kunokwelashwa ngomlomo. Inephampu yokufaka elawula inani lamakhemikhali okumele ahlinzekwe emzimbeni futhi ingaqashelwa kalula.Imakethe yomhlaba wonke yokwelapha nge-intravenous kanye ne-intravenous access device market kulindeleke ukuthi ikhule esikhathini sokubikezela. Isifo sikashukela, ukwanda kwezigameko zezingozi zomgwaqo, kanye nokwanda kwezinqubo zokuhlinza kulindeleke ukuthi kuqhubekisele phambili imboni. Imboni iphinde igqugquzelwe ukwanda kwesidingo sezindlela eziyinkimbinkimbi, njengokulethwa kwezidakamizwa ngaphandle kwezinaliti. I-COVID-19 Impact COVID-19 ine umthelela omuhle jikelele emakethe yokwelapha ye-IV. Ezigulini ezine-COVID-19 enzima ehlobene ne-acute breathing distress syndrome, kunikezwa ukwelashwa kwe-IV (ARDS). Isibonelo, ukusetshenziswa kwe-immune globulin ekwelapheni i-COVID-19 ARDS njenge i-adjuvant ekhangayo yokwelashwa kwe-ARDS enamandla ehlobene ne-COVID-19 yashicilelwa ku-Lancet Respiratory Medicine ngoNovemba 11, 2021 ngoba Inamandla okushintsha amasosha omzimba amaningi ngasikhathi sinye. Ngakho-ke, ngokwanda kwenani leziguli ezine-COVID-19 -ama-ARDS ahlobene, isidingo sokwelashwa kwe-IV kanye nemikhiqizo yokungena emthanjeni siyakhula.Izici Zokukhula Kwemakethe Ukwandisa Ukusebenza Nokukhula Kwabantu Abakhulakhulile Ukusabalala kwezifo ezihlukahlukene ezingelapheki ezidinga ukwelashwa kokungena kwemithambo kuye kwanda kule minyaka eyishumi edlule.Izifo ezingalapheki njengomdlavuza, ukwehluleka kwezinso kanye isifo senhliziyo, kanye nezindlela ezihlukahlukene zokuphila ezifana nomfutho wegazi ophakeme, isifo sikashukela, ukukhuluphala ngokweqile nokucindezeleka, zidinga ukunakekelwa okujulile ngesikhathi sokulala esibhedlela. Eminyakeni embalwa ezayo, ukwanda komthwalo wezifo ezingelapheki njengesifo senhliziyo, umdlavuza, unhlangothi nesifo sikashukela. , kuhlanganiswe nenani labantu asebekhulile, kuzokwandisa isidingo sokwelashwa ngomthambo.Intuthuko Yezobuchwepheshe Ama-catheter angena emthanjeni (aseduze nendawo emaphakathi), izesekeli ezinamathuluzi okuphepha, namaphampu okufakwa ithiphu aphakathi kwezinsiza zobuchwepheshe ezifaka isandla ekwelapheni okuphephile, okuphezulu kwekhwalithi ephezulu ( IVT) umkhuba.Njengoba ubuchwepheshe bezempilo buyisiyalo esiyinkimbinkimbi, esizindla futhi sixoxisane nsuku zonke ochwepheshe bezempilo abathintekayo ekunakekelweni kwesiguli egunjini labagula kakhulu, umkhakha wokunakekelwa uye waba nezinguquko eziphawulekayo ngenxa yokuhlanganiswa kobuchwepheshe obusha, futhi. amaphampu asezingeni eliphezulu angezinye zezinsiza zobuchwepheshe ezisiza ukufeza umkhuba wokwelapha nge-intravenous (IVT) ophephile futhi ophezulu.Izingqinamba Zemakethe Ukukhiqiza amaphampu kudinga imithetho eqinile kanye nokukhathazeka mayelana nezinkinga. Inqubo yokunikeza amalayisense amaphrojekthi amasha iqhutshwa ngokuphathelene nokukhiqizwa nokuqiniswa kwephampu. Ngaphezu kwalokho, ukukhuphuka kokubuyiselwa komkhiqizo ngenxa yokukhubazeka kokukhiqiza kuzobambezela ukwamukelwa kwalezi zindlela zokwelapha.Ngokwesibonelo, uFresenius Kabi ukhumbula i-Vigilant Agilia Drug Depot kanye neVolumat MC Agilia Infusion Pump in. Agasti 2019 ngenxa yezinkinga zesexwayiso sokufakwa, okubaluleke kakhulu i-Keep Vein Open (KVO) nezinye iziphazamisi zesofthiwe.Isithiyo esikhulu ekukhuleni kwemboni izinkinga ezihlobene nokusetshenziswa kwezindlela ze-IV kanye nemikhiqizo yokufakwa kwe-IV.End User Outlook Based Uma kubasebenzisi bokugcina, imakethe ihlukaniswe yaba izibhedlela, izikhungo zokuhlinza ezimotweni, kanye nemitholampilo. Ingxenye yesibhedlela izothatha ingxenye enkulu yemali engenayo emakethe yokwelashwa nge-intravenous (IV) kanye ne-venous access market ngo-2021. Lokhu kungenxa yokwanda kwenani. ukuhlinzwa okwenziwa uma kuqhathaniswa nezikhungo zokuhlinza i-ambulatory kanye nemitholampilo.Ngaphezu kwalokho, ukukhula kwengxenye kwakubangelwa ukwanda kokusetshenziswa kwe-intravenous therapy ezibhedlela, okuhlanganisa i-intravenous antibiotic therapy, izidakamizwa zeziguli ze-comatose, izidakamizwa ezingeke zithathwe ngomlomo, ukungenelela. i-radiology, izidakamizwa ezilwa nomdlavuza, i-hemodialysis, ukuphinda amamephu esampula yegazi, kanye nokumpontshelwa igazi .Imakethe yokwelashwa kwe-IV kanye namadivayisi okufinyelela e-venous iyakhula ngenxa yentuthuko yezobuchwepheshe kanye nokutshalwa kwezimali kwesibhedlela.I-Application Outlook Ngesisekelo sohlelo lokusebenza, imakethe ihlukaniswe yaba ukuphathwa kwezidakamizwa. , imikhiqizo esekelwe egazini, izixazululo zokudla okunomsoco kanye ne-buffer, kanye nemikhumbi yokunweba. Ngo-2021, ingxenye ye-Volume Expander izothola isabelo semali esibalulekile ekwelapheni nge-intravenous (IV) kanye nemakethe yokufinyelela emithanjeni. - abasubathi abazwelayo; kodwa-ke, lokhu kufanele kugcinelwe abasubathi bezinga eliphezulu abanomlando wezimpawu eziqinile ngaphansi kokuqapha okuhle.Abanye abasubathi bangase bazuze ngokusebenzisa i-expander.Uketshezi olufakwa emthanjeni kanye nezibophelelo ze-plasma akuvunyelwe emiqhudelwaneni elawulwa yi-WADA.Eningini labasubathi, Ukwelashwa okujwayelekile kwe-IV akuyona inketho engcono kakhulu.Uhlobo lwe-Outlook Ngokusekelwe ohlotsheni, imakethe ihlukaniswe yaba ama-catheter afakwa emthanjeni, amaphampu afakwayo, izinaliti ze-hypodermic, amachweba afakelwayo, nokunye.Ngo-2021, ingxenye ye-catheter efakwa emthanjeni izothatha isabelo esikhulu semali engenayo ukwelapha nge-intravenous (IV) kanye nemakethe yokungena emthanjeni.Lokhu kungenxa yokwanda kokusetshenziswa kwama-catheter e-IV phakathi nezinqubo zokuhlinzwa zokwelashwa kwe-IV kanye nangesikhathi sokudluliselwa kwegazi, imithi, nezinye izakhi ezingxenyeni ezihlukahlukene zomzimba. ifakwe emgodini womzimba noma ilume.I-intravenous catheter iyi-catheter efakwa emthanjeni esetshenziselwa ukuletha izidakamizwa, uketshezi, noma ezinye izindlela zokwelapha ngokuqondile egazini.Imvamisa ifakwa emthanjeni osengalweni, nakuba ingafakwa nasegazini. Intamo, isifuba, noma igroin.Ama-catheter afakwa emthanjeni eza ngosayizi nangezinhlobo ezahlukene, kuya ngokusetshenziswa kwawo okuhlosiwe.I-Regional Outlook Ngokusekelwe esifundeni, imakethe ihlukaniswe eNyakatho Melika, eYurophu, e-Asia Pacific naseLatin America, eMpumalanga Ephakathi nase-Afrika. Ngo-2021, iNyakatho Melika iyisifunda esihamba phambili ekwelapheni nge-intravenous (IV) kanye nemakethe yokufinyelela kwe-venous ngokubamba isabelo semakethe esiphezulu kakhulu semakethe. izingozi zomgwaqo, ukukhula okuphezulu kwezigameko zokuhlukumezeka, kanye nokwenyuka kwezimali ezitshaliwe kuhulumeni ekuthuthukiseni izikhungo zezokwelapha ezingcono kanye nemisebenzi ye-R&D.Umbiko wocwaningo lwemakethe uhlanganisa ukuhlaziywa kwababambe iqhaza ababalulekile bemakethe.Izinkampani ezinkulu ezishiwo embikweni zihlanganisa u-B. Braun Melsungen AG, I-Medtronic PLC, Terumo Corporation, Fresenius SE & Co. KGaA, Cardinal Health, Inc., Pfizer, Inc., Teleflex, Inc., Baxter International, Inc., Smiths Group PLC kanye ne-AngioDynamics, Inc. Sebenzisa Amasu ku-Intravenous (IV ) Imakethe yokwelapha kanye ne-Intravenous Access Market March 2022: UFresenius Kabi usayine isivumelwano sokuthola i-Fresenius Kabi, inkampani yezokunakekelwa kwezempilo emhlabeni wonke. ukuxubana okubanzi kwemikhiqizo ezibhedlela zase-US. Disemba 2021: U-Baxter wenza ubambiswano nomhlinzeki wezobuchwepheshe bezokwelapha wase-US u-Hillrom. Ngalokhu kubambisana, lezi zinkampani ezimbili zihlose ukuhlanganisa amabhizinisi amabili amakhulu ezobuchwepheshe bezokwelapha ukuze kuzuzwe umbono ofanayo wokuguqula ukunakekelwa kwezempilo emhlabeni wonke kanye nokwenza ngcono ukunakekelwa kwesiguli. .May 2021: I-Smiths Medical yenza ubambiswano nenkampani yobuchwepheshe bezokwelapha i-Ivenix. Ngalolu budlelwano, lezi zinkampani ezimbili zihlose ukunikeza izixazululo eziningi zokulawula ukumnika. Ngaphezu kwalokho, i-Smiths Medical izohlinzeka ngokutshalwa kwezimali kwamasu kubambiswano besikhathi eside obuklanyelwe ukuguqula ukuphathwa kokuxubana. futhi kuthuthukiswe impilo yesiguli, kuyilapho kuhlangatshezwana nezidingo zabahlinzeki bezempilo. Ngo-April 2021: I-B. Braun Medical yethula uhlelo olusha, i-Peripheral Advantage, ukuthuthukisa ulwazi lweziguli ngokwelashwa ngomthambo we-peripheral. amathuluzi athuthukisiwe okunikeza amandla abahlengikazi ukuze bathole impumelelo yokuqala futhi basize ukugwema ubunkimbinkimbi obuhambisana nokwelashwa kwe-peripheral IV.Julayi 2019: U-Baxter uthola imvume ye-US Food and Drug Administration (i-FDA) ye-Myxredlin. kanye nezinye izilungiselelo zokunakekelwa okujulile futhi ineshalofu lokuphila elibanzi lezinsuku ezingu-30 noma izinyanga ezingu-24 ekamelweni lokushisa uma ifakwe esiqandisini ephaketheni lokuqala ukuze kuqinisekiswe ukuvikeleka ekukhanyeni.Imibiko: Ngumsebenzisi Wokugcina • Izibhedlela • Izikhungo Zokuhlinza I-Ambulatory • Imitholampilo Ngokufaka Isicelo • Ukuphathwa Kwemithi • Imikhiqizo Yegazi • Izixazululo Zezakhi Nezivikeli • Imikhumbi Yokusabalalisa Ngohlobo • Ama-Catheter Okungena Ngemithambo • Amaphampu Okufakwayo • Izinaliti Ze-Hypodermic • Izimbobo Ezifakwayo • Okunye NgeJografi • ENyakatho Melika o USo Canadao Mexico Yonke indawo yaseNyakatho Melika • I-Europe Germany o UKo France Russia Spain Italy o I-Europe yonke • I-Asia Pacific China o Japan India Korea Singapore Malaysia o Rest of Asia Pacific • LAMEAo Brazil Argentina UAE Saudi Arabia South Africa Nigeria LAMEA Rest Company Profile• B. Braun Melsungen AG • Medtronic PLC• Terumo Corporation• Fresenius SE & Co. KGaA• Cardinal Health, Inc.• Pfizer, Inc.• Teleflex, Inc.• Baxter International, Inc.• Smiths Group PLC• AngioDynamics, Inc. Iminikelo Eyingqayizivele • Ukufakwa Okuphelele • Amathebula Emakethe Abanzi Kakhulu Nedatha • Imodeli Esekelwe Okubhaliselwe Iyatholakala • Intengo Engcono Kakhulu Iqinisekisiwe • Ucwaningo Oluqinisekisiwe Lwangemuva Kokuthengisa Lusekelwa Ukwenziwa Ngokwezifiso okungu-10% Funda umbiko ogcwele mahhala: https://www .reportlinker.com/p06283441/?utm_source=GNWAbout ReportlinkerReportLinker yisixazululo esiwine umklomelo socwaningo lwemakethe.Ukuthola kweReportlinker futhi ihlele idatha yemboni yakamuva ukuze uthole lonke ucwaningo lwemakethe oludingayo ngokushesha endaweni eyodwa.